Professor Jake Shortt is a clinician scientist who is co-appointed by Monash Health as Director of Clinical Haematology and by Monash University as the Head of Haematology Research at the School of Clinical Sciences. Monash Health provides lymphoma services to the largest Australian healthcare network in the Australian state of Victoria. He is also an Honorary Clinical Professor at the Sir Peter MacCallum Department of Oncology, University of Melbourne.
Professor Shortt is group leader of the 'Blood Cancer Therapeutics Laboratory' at Monash, seeking to discover and translate new lymphoma treatments to the clinic. As a clinician scientist his research covers the full translational spectrum from scientific discovery to advanced clinical trials and registry initiatives. For more than a decade his research has focussed on poor-risk lymphoid cancers, particularly those hallmarked by activation of a gene called 'MYC' which features in some of the most aggressive lymphomas.